StonvexLoading…
StonvexStonvexStonvexCore line items from OPCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.65B | $5.00B | $4.30B | $3.87B |
Operating Income | $337.91M | $321.83M | $314.60M | $240.23M |
Net Income | $207.59M | $211.82M | $267.09M | $150.56M |
EPS (Diluted) | $1.27 | $1.23 | $1.48 | $0.83 |
Total Assets | $3.46B | $3.42B | $3.22B | $3.11B |
Total Liabilities | $2.13B | $2.02B | $1.80B | $1.73B |
Cash & Equivalents | $232.62M | $412.56M | $343.85M | $294.19M |
Free Cash Flow OCF − CapEx | $217.14M | $287.79M | $329.43M | $232.19M |
Shares Outstanding | 156.86M | 166.26M | 174.58M | 181.96M |